Argan (AGX) Shares Just Moved, So What Is Driving Attention Now?

Argan (AGX) has given income focused investors something new to assess, with the board approving a 40% lift in the quarterly dividend to US$0.70 per share, payable on October 30, 2026.

Recent trading has been choppy for Argan. The share price fell 27.68% over the past 30 days and declined 35.52% across the last 90 days, even though the year to date share price return is 26.93% and the 1 year total shareholder return is 80.50%. These returns have been supported by very large 3 year and 5 year total shareholder returns of roughly 9x, which now appear to be facing a short term reset as investors digest the stronger earnings, ongoing buybacks and the richer dividend.

Scan income focused opportunities moving on dividend strength and shareholder returns with our curated 6 dividend fortresses, aligned with stories like Argan's latest payout lift and long run performance reset.

The share price reset, richer dividend and completed buyback leave Argan looking either freshly mispriced or already fully harvested. Is most of the gain now in the rearview mirror, or does the valuation still point to upside?

Most Popular Narrative: 34.6% Undervalued

Argan's most followed narrative sets a fair value of $633 against a last close of $413.74, which frames the recent dividend lift inside a much bigger earnings and backlog story.

Record backlog and continued project wins across gas, renewables, water treatment, and recycling plants provide multi-year revenue visibility, indicating potential for increased operating leverage and higher gross margins as larger projects are executed successfully.

Read the complete narrative. Read the complete narrative.

Want to see what is behind that fair value gap? The narrative leans heavily on compounding top line expectations, only slightly lower profit margins and a richer future earnings multiple. Curious which mix of growth, profitability and discount rate inputs has to hold together for that story to work?

Result: Fair Value of $633 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

Still, Argan's heavy tilt toward large gas projects and reliance on a small set of complex contracts could quickly challenge that undervaluation story if conditions shift.

Find out about the key risks to this Argan narrative.

Another View On Argan's Valuation

Argan may look inexpensive compared with the $633 fair value narrative, but the current P/E of 32.4x tells a more restrained story. It roughly matches the US Construction industry on 32.4x, yet it sits above a reference ratio of 26.7x. That gap suggests valuation risk if sentiment or growth assumptions soften.

For investors who rely on earnings multiples, the stock also appears only slightly cheaper than peers at 33.5x. In practice, that means less obvious multiple-based upside and more dependence on Argan continuing to meet the high expectations already reflected in the price. Which perspective feels more convincing if volatility returns?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Mixed messages from Argan's price and payout can feel confusing, so move quickly, review the data yourself and weigh both sides using 2 key rewards and 2 important warning signs

Looking for more investment ideas beyond Argan?

If Argan has you rethinking income and valuation, do not stop there. Cast a wider net and pressure test your next move against fresh market ideas.

• Target dependable income by comparing payout strength and price action across a curated 6 dividend fortresses that surfaces candidates built around robust shareholder distributions.
• Hunt for potential mispricings using our focused 31 high quality undervalued stocks that filters for strong fundamentals trading at a discount to underlying business quality.
• Secure your downside first and then think about upside with a carefully selected 11 resilient stocks with low risk scores designed to spotlight companies with more resilient profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com